DE69209099D1 - Sulfonamidderivate - Google Patents

Sulfonamidderivate

Info

Publication number
DE69209099D1
DE69209099D1 DE69209099T DE69209099T DE69209099D1 DE 69209099 D1 DE69209099 D1 DE 69209099D1 DE 69209099 T DE69209099 T DE 69209099T DE 69209099 T DE69209099 T DE 69209099T DE 69209099 D1 DE69209099 D1 DE 69209099D1
Authority
DE
Germany
Prior art keywords
sulfonamide derivatives
sulfonamide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69209099T
Other languages
English (en)
Other versions
DE69209099T2 (de
Inventor
David Waterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca SAS
Syngenta Ltd
Original Assignee
Zeneca Pharma SA
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Pharma SA, Zeneca Ltd filed Critical Zeneca Pharma SA
Publication of DE69209099D1 publication Critical patent/DE69209099D1/de
Application granted granted Critical
Publication of DE69209099T2 publication Critical patent/DE69209099T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69209099T 1991-01-17 1992-01-10 Sulfonamidderivate Expired - Fee Related DE69209099T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91400098 1991-01-17
EP91401882 1991-07-08

Publications (2)

Publication Number Publication Date
DE69209099D1 true DE69209099D1 (de) 1996-04-25
DE69209099T2 DE69209099T2 (de) 1996-11-14

Family

ID=26129951

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69209099T Expired - Fee Related DE69209099T2 (de) 1991-01-17 1992-01-10 Sulfonamidderivate

Country Status (16)

Country Link
US (1) US5236948A (de)
EP (1) EP0495594B1 (de)
JP (1) JPH0551374A (de)
KR (1) KR920014791A (de)
AU (1) AU645159B2 (de)
CA (1) CA2058651A1 (de)
CS (1) CS9200024A3 (de)
DE (1) DE69209099T2 (de)
FI (1) FI920214A (de)
GB (1) GB9200482D0 (de)
HU (1) HUT59917A (de)
IE (1) IE914575A1 (de)
IL (1) IL100483A0 (de)
MX (1) MX9200169A (de)
NO (1) NO920220L (de)
NZ (1) NZ241287A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914005A1 (en) * 1990-12-14 1992-06-17 Zeneca Ltd Novel intermediates
DE69206725T2 (de) * 1991-09-10 1996-05-02 Zeneca Ltd Benzolsulfonamidderivate als 5-Lipoxygenasehemmer
CA2094465A1 (en) * 1992-04-23 1993-10-24 Pierre Andre Raymond Bruneau Cycloalkane derivatives
CA2095005A1 (en) * 1992-05-12 1993-11-13 Philip Neil Edwards Hydroxylamine derivatives
CA2095006A1 (en) * 1992-05-12 1993-11-13 Philip Neil Edwards Oxime derivatives
AU4444393A (en) * 1992-09-01 1994-03-10 Zeneca Limited Pyrrolidine derivatives
GR920100426A (el) * 1992-10-08 1994-06-30 Ici Pharma Παράγωγα βενζολοσουλφοναμιδίου.
ES2055657B1 (es) * 1992-10-08 1995-02-16 Ici Plc Derivados de bencenosulfonamida.
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
EP1879881A2 (de) * 2005-04-14 2008-01-23 Bristol-Myers Squibb Company Inhibitoren der 11-beta-hydroxysteroiddehydrogenase vom typ i
FR2954943B1 (fr) * 2010-01-07 2013-03-01 Sanofi Aventis Derives de pyridino-pyridinones arylsulfonamides, leur preparation et leur application en therapeutique

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3743737A (en) * 1970-05-21 1973-07-03 Smith Kline French Lab 3-sulfonamido-4-hydroxyphenyl-2-piperindinylcarbinol compositions
US3661917A (en) * 1970-05-21 1972-05-09 Smith Kline French Lab 3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
IE56702B1 (en) * 1982-12-01 1991-11-06 Usv Pharma Corp Antiinflammatory antiallergic compounds
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4876346A (en) * 1985-05-02 1989-10-24 American Home Products Corporation Quinoline compounds
EP0271287A3 (de) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Chinolindicarbonsäuren und ihre Amide
US4920133A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920130A (en) * 1987-11-02 1990-04-24 Rorer Pharamceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4918081A (en) * 1988-06-20 1990-04-17 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene d4
EP0349062A1 (de) * 1988-06-27 1990-01-03 Merck Frosst Canada Inc. Chinolinetheralkansäuren
IL92620A0 (en) * 1988-12-23 1990-08-31 Ici Pharma Cycloalkane derivatives
GB8927287D0 (en) * 1988-12-23 1990-01-31 Ici Plc Cyclic ether derivatives
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
IE64358B1 (en) * 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
GB9018134D0 (en) * 1989-09-29 1990-10-03 Ici Plc Heterocyclic derivatives
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives

Also Published As

Publication number Publication date
HU9200129D0 (en) 1992-04-28
EP0495594B1 (de) 1996-03-20
HUT59917A (en) 1992-07-28
EP0495594A1 (de) 1992-07-22
CA2058651A1 (en) 1992-07-18
US5236948A (en) 1993-08-17
KR920014791A (ko) 1992-08-25
CS9200024A3 (en) 1992-08-12
NO920220D0 (no) 1992-01-16
AU9004391A (en) 1992-07-23
GB9200482D0 (en) 1992-02-26
AU645159B2 (en) 1994-01-06
DE69209099T2 (de) 1996-11-14
IE914575A1 (en) 1992-07-29
MX9200169A (es) 1992-10-30
FI920214A0 (fi) 1992-01-17
FI920214A (fi) 1992-07-18
NZ241287A (en) 1994-06-27
NO920220L (no) 1992-07-20
JPH0551374A (ja) 1993-03-02
IL100483A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
FI942090A (fi) Sulfonamidiherbisidit
DE69208877D1 (de) Chinuclidinderivate
NO922182L (no) Krystallinske oksatiolan-derivater
DE69119329D1 (de) Actinonin-Derivate
FI933167A0 (fi) N-alkylkinuklidiniumsalter som substans-p antagonister
DE69212948D1 (de) Styrol-Derivate
FI925523A0 (fi) Hydroxi- och alkoxipyridinderivat
FI921182A (fi) Velangummi som snabbt hydratiseras
DE69125099D1 (de) Indolderivate
FI925763A (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
FI921435A (fi) Skydd foer saenkpump i svaora foerhaollanden
FI922759A (fi) Loesningsmedelskompositioner foer anvaendning i tryckkaensligt kopieringspapper
DE69130255D1 (de) Oxadolderivate
FI923724A (fi) Monterings- och distansanordning foer braenslestavarna i en kokvattenreaktor
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
DK0472733T3 (da) Phenantrenderivater
FI925206A0 (fi) Rengoerningsprodukt i vaetskeform
FI935566A (fi) Insertionsmutationer i mycobakterier
FI924750A0 (fi) Zirkoniumbaserad legering foer komponenter i kaernreaktorer
DE69209099D1 (de) Sulfonamidderivate
FI922180A (fi) Tuggummi innehaollande tuggummibas i en valsningsblandning
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
MX9206710A (es) Derivados de piridinol
FI920998A (fi) Skaermad hytt i modulkonstruktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee